Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This reflects a minor site update.
    Difference
    0.1%
    Check dated 2026-03-11T14:26:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site, and the lapse funding notice along with the prior Revision: v3.4.1 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-02-11T04:42:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new funding/operating status notice was added, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    1%
    Check dated 2026-02-04T05:20:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Show glossary and No FEAR Act Data, removed No FEAR Act data, and updated the revision to v3.4.0 from v3.3.4.
    Difference
    0.4%
    Check dated 2026-01-28T03:19:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.4, replacing v3.3.3. This is a minor maintenance update that does not affect content or functionality.
    Difference
    0.1%
    Check dated 2026-01-14T00:42:51.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; the HHS Vulnerability Disclosure and the previous Revision: v3.3.2 label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-23T08:23:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.